Annual EBIT
-$37.41 M
+$3.50 M+8.56%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual earnings before interest & taxes is -$37.41 million, with the most recent change of +$3.50 million (+8.56%) on December 31, 2023.
- During the last 3 years, UBX annual EBIT has risen by +$55.14 million (+59.58%).
- UBX annual EBIT is now -98.51% below its all-time high of -$18.84 million, reached on December 31, 2016.
Performance
UBX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.48 M
-$1.20 M-22.77%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly earnings before interest & taxes is -$6.48 million, with the most recent change of -$1.20 million (-22.77%) on September 30, 2024.
- Over the past year, UBX quarterly EBIT has increased by +$7.74 million (+54.41%).
- UBX quarterly EBIT is now -384.38% below its all-time high of $2.28 million, reached on December 31, 2022.
Performance
UBX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$21.89 M
+$7.74 M+26.11%
September 30, 2024
Summary
- As of February 8, 2025, UBX TTM earnings before interest & taxes is -$21.89 million, with the most recent change of +$7.74 million (+26.11%) on September 30, 2024.
- Over the past year, UBX TTM EBIT has increased by +$8.90 million (+28.90%).
- UBX TTM EBIT is now -142.13% below its all-time high of -$9.04 million, reached on March 31, 2017.
Performance
UBX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
UBX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | +54.4% | +28.9% |
| 3 y3 years | +59.6% | -384.4% | +46.5% |
| 5 y5 years | +51.0% | -384.4% | +46.5% |
UBX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.0% | -384.4% | +64.2% | at high | +63.9% |
| 5 y | 5-year | at high | +59.6% | -384.4% | +76.9% | at high | +76.3% |
| alltime | all time | -98.5% | +59.6% | -384.4% | +76.9% | -142.1% | +76.3% |
Unity Biotechnology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.48 M(+22.8%) | -$21.89 M(-26.1%) |
| Jun 2024 | - | -$5.28 M(-8.8%) | -$29.62 M(-23.9%) |
| Mar 2024 | - | -$5.79 M(+33.4%) | -$38.92 M(+4.0%) |
| Dec 2023 | -$37.41 M(-8.6%) | -$4.34 M(-69.5%) | -$37.41 M(+21.5%) |
| Sep 2023 | - | -$14.22 M(-2.4%) | -$30.79 M(+4.7%) |
| Jun 2023 | - | -$14.57 M(+240.7%) | -$29.41 M(+8.6%) |
| Mar 2023 | - | -$4.28 M(-287.7%) | -$27.08 M(-33.8%) |
| Dec 2022 | -$40.91 M(-28.9%) | $2.28 M(-117.7%) | -$40.91 M(-22.9%) |
| Sep 2022 | - | -$12.84 M(+4.9%) | -$53.06 M(-5.0%) |
| Jun 2022 | - | -$12.24 M(-32.4%) | -$55.88 M(-7.9%) |
| Mar 2022 | - | -$18.11 M(+83.5%) | -$60.67 M(+5.4%) |
| Dec 2021 | -$57.55 M(-37.8%) | -$9.87 M(-37.0%) | -$57.55 M(-13.4%) |
| Sep 2021 | - | -$15.66 M(-8.1%) | -$66.47 M(-14.6%) |
| Jun 2021 | - | -$17.04 M(+13.8%) | -$77.87 M(-2.0%) |
| Mar 2021 | - | -$14.98 M(-20.3%) | -$79.50 M(-14.1%) |
| Dec 2020 | -$92.55 M | -$18.79 M(-30.5%) | -$92.55 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$27.05 M(+44.9%) | -$91.78 M(+6.2%) |
| Jun 2020 | - | -$18.67 M(-33.4%) | -$86.44 M(-5.2%) |
| Mar 2020 | - | -$28.04 M(+55.5%) | -$91.21 M(+8.4%) |
| Dec 2019 | -$82.18 M(+7.6%) | -$18.03 M(-17.0%) | -$84.16 M(-4.7%) |
| Sep 2019 | - | -$21.71 M(-7.4%) | -$88.26 M(+3.5%) |
| Jun 2019 | - | -$23.44 M(+11.7%) | -$85.30 M(+5.4%) |
| Mar 2019 | - | -$20.98 M(-5.2%) | -$80.90 M(+5.9%) |
| Dec 2018 | -$76.40 M(+67.5%) | -$22.13 M(+18.1%) | -$76.40 M(+13.9%) |
| Sep 2018 | - | -$18.74 M(-1.6%) | -$67.05 M(+11.0%) |
| Jun 2018 | - | -$19.04 M(+15.5%) | -$60.39 M(+13.8%) |
| Mar 2018 | - | -$16.48 M(+28.9%) | -$53.05 M(+16.3%) |
| Dec 2017 | -$45.61 M(+142.0%) | -$12.79 M(+5.8%) | -$45.61 M(+39.0%) |
| Sep 2017 | - | -$12.08 M(+3.3%) | -$32.82 M(+58.3%) |
| Jun 2017 | - | -$11.70 M(+29.4%) | -$20.74 M(+129.4%) |
| Mar 2017 | - | -$9.04 M | -$9.04 M |
| Dec 2016 | -$18.84 M | - | - |
FAQ
- What is Unity Biotechnology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Unity Biotechnology?
- What is Unity Biotechnology annual EBIT year-on-year change?
- What is Unity Biotechnology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Unity Biotechnology?
- What is Unity Biotechnology quarterly EBIT year-on-year change?
- What is Unity Biotechnology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Unity Biotechnology?
- What is Unity Biotechnology TTM EBIT year-on-year change?
What is Unity Biotechnology annual earnings before interest & taxes?
The current annual EBIT of UBX is -$37.41 M
What is the all time high annual EBIT for Unity Biotechnology?
Unity Biotechnology all-time high annual earnings before interest & taxes is -$18.84 M
What is Unity Biotechnology annual EBIT year-on-year change?
Over the past year, UBX annual earnings before interest & taxes has changed by +$3.50 M (+8.56%)
What is Unity Biotechnology quarterly earnings before interest & taxes?
The current quarterly EBIT of UBX is -$6.48 M
What is the all time high quarterly EBIT for Unity Biotechnology?
Unity Biotechnology all-time high quarterly earnings before interest & taxes is $2.28 M
What is Unity Biotechnology quarterly EBIT year-on-year change?
Over the past year, UBX quarterly earnings before interest & taxes has changed by +$7.74 M (+54.41%)
What is Unity Biotechnology TTM earnings before interest & taxes?
The current TTM EBIT of UBX is -$21.89 M
What is the all time high TTM EBIT for Unity Biotechnology?
Unity Biotechnology all-time high TTM earnings before interest & taxes is -$9.04 M
What is Unity Biotechnology TTM EBIT year-on-year change?
Over the past year, UBX TTM earnings before interest & taxes has changed by +$8.90 M (+28.90%)